Open AccessThe Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients
Author(s) -
Jeong-Hoon Lim,
Soie Kwon,
Yena Jeon,
Young Hoon Kim,
Hyunwook Kwon,
Yon Su Kim,
Hajeong Lee,
Yong-Lim Kim,
ChanDuck Kim,
Sun-Hee Park,
Jong Soo Lee,
Kyung Don Yoo,
Hyung Eun Son,
Jong Cheol Jeong,
Jeonghwan Lee,
Jung Pyo Lee,
JangHee Cho
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000004228
Subject(s) - medicine , hazard ratio , renal function , confidence interval , creatinine , diabetes mellitus , kidney transplantation , transplantation , proportional hazards model , urology , gastroenterology , surgery , endocrinology
The efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) have not been investigated in kidney transplant recipients (KTRs) with diabetes. We evaluated the impact of SGLT2i in a multicenter cohort of diabetic KTRs.